Table 2.
Characterization of urinary isolates into different resistance phenotypes and distribution of FP resistance
| Resistance phenotype | Fosfomycin Sensitive (%)* |
|---|---|
| PS (30) | 29 (96.7) |
| MDR (95) | 87 (91.6) |
| E. coli (67) | 61 (91.0) |
| Klebsiella pneumoniae (16) | 15 (93.8) |
| P. aeruginosa (5) | 5 (100) |
| Other Enterobacterales (2) | 2 (100) |
| Enterococcus spp. (5) | 4 (80) |
| XDR (23) | 21 (91.3) |
| E. coli (7) | 7 (100) |
| Klebsiella pneumoniae (12) | 10 (83.3) |
| P. aeruginosa (2) | 2 (100) |
| Other Enterobacterales (2) | 2 (100) |
| PDR (2) | 2 (100) |
| ESBL (137) | 128 (93.3) |
| E. coli (92) | 86 (93.5) |
| Klebsiella pneumoniae (31) | 28 (90.3) |
| P. aeruginosa (9) | 9 (100) |
| Other Enterobacterale (5) | 5 (100) |
| Non-ESBL (36) | 35 (97.2) |
| CRGNB (89) | 80 (89.9) |
| Non-CRGNB (84) | 83 (98.8) |
| HLAR (4) | 3 (75) |
| Non-HLAR (4) | 3 (100) |
| Others (31) | 31 (100) |
* Fosfomycin intermediate category is included in Fosfomycin susceptible, extended-spectrum lactamase (ESBL), carbapenem-resistant GNB (CRGNB), high-level aminoglycoside resistance (HLAR), Pan-sensitive (PS), multi-drug resistant (MDR), extremely drug-resistant (XDR) and pan-drug-resistant (PDR).